Mercapturate pathway metabolites of sotorasib, a covalent inhibitor of KRAS(G12C), are associated with renal toxicity in the Sprague Dawley rat
This combination is utilized in research settings to examine muscle recovery, protein synthesis pathways, fat metabolism, sleep quality, and endocrine signaling interactions under controlled laboratory conditions
336,337 The inhibitors of IDO are currently under investigation in clinical trials for solid cancer to enhance primary anticancer therapy, including antibodies and immune checkpoint inhibitors
BPC-157 , , ,
When the medicine is eventually approved, prescribers will follow the MHRA-approved Summary of Product Characteristics
Contaminants, endotoxins, and inaccurate dosing are real-world hazards that may cause harm independent of the peptide's own pharmacology